News
BNY Mellon Dynamic Value Fund (Class A at NAV) returned 5.00% during the second quarter of 2025. Read more here.
Stockhead on MSN20h
Morgans spotlights nine healthcare stocks with upcoming catalysts after “upbeat” Bioshares Biotech Summit
Morgan's Scott Power highlights nine ASX healthcare companies from the 2025 Bioshares Biotech Summit with catalysts over next six ... Read More The post Morgans spotlights nine healthcare stocks with ...
DelveInsight's GnRH Receptor Antagonists Market Size, Target Population, Competitive Landscape & Market Forecast report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback